Jump to comment:
- Page navigation anchor for Response to Cleo Mavripilis, from the authors.Response to Cleo Mavripilis, from the authors.
We thank Dr Mavripilis for her letter. As she so well described it, our intent was to provide a structure to help clinicians implement shared decision making in practice.
In this regard, we would like to let you know about two forthcoming papers in this series. The first will describe tools to support conversation about the harms and benefits of preventive health care, and to address the challenge of risk communication in shared decision-making. The second will take a deeper look into patient values and preferences related to screening.
Dr Mavripilis expressed concern about incorporating shared decision making with some patients, such as those with a lower level of health literacy. We share this concern. However, shared decision-making requires education on both sides of the clinician’s desk. In this regard, we recommend the additional article titled ‘12 myths about shared decision making’.
Finally, we invite more readers to contribute to this discussion, for example, by posting a rapid response.
Competing Interests: None declared. - Page navigation anchor for RE: Shared Decision making in preventive health careRE: Shared Decision making in preventive health care
Many thanks to the authors for providing a breakdown of the process of shared decision making in preventive health care. Having a structure to follow makes it more approachable and doable than simply suggesting this be done.
I have used the CTFPHC tools to do discuss screening tests with patients, especially for prostate cancer and lung cancer screening and for discouraging women under 50 from wanting a screening mammogram. I do find as mentioned in the article it takes patients a while to absorb the information and giving them a printout of the tool ( I often circle the number of persons harmed and numbers who benefit) to read over later is helpful with the message that they we can re-discuss at any time.
I realize there are limitations to how much you can discuss in an article such as this, but it would be helpful to make some reference to how difficult this task is and the nuances of discussing harms vs benefits. When I have presented the CTFPHC tools to my family physician and nurse practitioner colleagues , this often leaves them scratching their heads as to how to balance numbers of patients harmed by the test vs numbers of patients who benefit. So a patient with no medical training,possibly less knowledge of statistics and often a different level of education will frequently find it very difficult to understand. I will read your references on shared decision making, but I often do question myself on how much value to place on a false positive screen...
Show MoreCompeting Interests: None declared.